Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy

Microdystrophin Ameliorates Muscular Dystrophy in the Canine Model of Duchenne Muscular Dystrophy

(2013) Jin-Hong Shin et al.   MOLECULAR THERAPY

The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5' X-linked dilated cardiomyopathy

(2012) Marcella Neri et al.   BMC Medical Genetics

Interplay Between Heart and Skeletal Muscle Disease in Heart Failure

(2012) Elizabeth M. McNally et al.   CIRCULATION RESEARCH

Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges

(2012) Virginia Arechavala-Gomeza et al.   CURRENT GENE THERAPY

Progress in gene therapy of dystrophic heart disease

(2012) Y Lai et al.   GENE THERAPY

Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice

(2012) Chady H. Hakim et al.   JOURNAL OF APPLIED PHYSIOLOGY

AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy

(2012) Brian Bostick et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Pip6-PMO, A New Generation of Peptide-oligonucleotide Conjugates With Improved Cardiac Exon Skipping Activity for DMD Treatment

(2012) Corinne Betts et al.   Molecular Therapy-Nucleic Acids

AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice

(2011) Brian Bostick et al.   MOLECULAR THERAPY

Pip5 Transduction Peptides Direct High Efficiency Oligonucleotide-mediated Dystrophin Exon Skipping in Heart and Phenotypic Correction in mdx Mice

(2011) HaiFang Yin et al.   MOLECULAR THERAPY

Long-Term Systemic Administration of Unconjugated Morpholino Oligomers for Therapeutic Expression of Dystrophin by Exon Skipping in Skeletal Muscle: Implications for Cardiac Muscle Integrity

(2011) Alberto Malerba et al.   Nucleic Acid Therapeutics

Diaphragm rescue alone prevents heart dysfunction in dystrophic mice

(2010) Alastair Crisp et al.   HUMAN MOLECULAR GENETICS

Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice

(2010) Dejia Li et al.   JOURNAL OF PATHOLOGY

Gender influences cardiac function in the mdx model of duchenne cardiomyopathy

(2010) Brian Bostick et al.   MUSCLE & NERVE

Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice

(2009) Dejia Li et al.   HUMAN MOLECULAR GENETICS

Alterations in mitochondrial function as a harbinger of cardiomyopathy: Lessons from the dystrophic heart

(2009) Yan Burelle et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy

(2009) Rita Wen Kaspar et al.   Journal of the American Academy of Nurse Practitioners

Effects of Exercise Training on Myocardial Energy Metabolism and Ventricular Function Assessed by Quantitative Phosphorus-31 Magnetic Resonance Spectroscopy and Magnetic Resonance Imaging in Dilated Cardiomyopathy

(2008) Meinrad Beer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs

(2008) Yongping Yue et al.   MOLECULAR THERAPY

Emergent Dilated Cardiomyopathy Caused by Targeted Repair of Dystrophic Skeletal Muscle

(2008) DeWayne Townsend et al.   MOLECULAR THERAPY

Cardiac Expression of a Mini-dystrophin That Normalizes Skeletal Muscle Force Only Partially Restores Heart Function in Aged Mdx Mice

(2008) Brian Bostick et al.   MOLECULAR THERAPY

Prevention of Dystrophin-Deficient Cardiomyopathy in Twenty-One-Month-Old Carrier Mice by Mosaic Dystrophin Expression or Complementary Dystrophin/Utrophin Expression

(2007) Brian Bostick et al.   CIRCULATION RESEARCH